Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
ESMO Open|October 26, 2024
ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncologyK H J Lim, K Kamposioras, E Élez, et al.
Breast Cancer Research and Treatment|February 11, 2018
Breast cancer subtype and survival by parity and time since last birthH De Mulder, A Laenen, H Wildiers, et al.
ESMO Open|July 3, 2021
The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey IIK H J Lim, K Murali, K Kamposioras, et al.
ESMO Open|February 18, 2021
The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaborationS Banerjee, K H J Lim, K Murali, et al.
Journal of Cancer Research and Clinical Oncology|January 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohortS Thijssen, H Wildiers, K Punie, et al.
ESMO Open|January 10, 2022
The impact of COVID-19 on oncology professionals-one year on: lessons learned from the ESMO Resilience Task Force survey seriesK H J Lim, K Murali, E Thorne, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 1, 2017
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitorsT van Cann, T Loyson, A Verbiest, et al.
ESMO Open|June 7, 2023
COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databasesP Martin, Z Tsourti, J Ribeiro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2021
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancerA Bardia, S M Tolaney, K Punie, et al.
ESMO Open|November 10, 2022
Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the futureT Geukens, M Brandão, A Laenen, et al.
Pageof 3